CYRX vs MRTN
CYRX: Cryoport is the leading provider of end-to-end temperature-controlled supply chain solutions specifically built for cell and gene therapies, from preclinical development through global commercialization. MRTN: A leading temperature-sensitive truckload carrier providing specialized refrigerated and dry transportation services for the food and consumer goods industries.
Side-by-side fundamentals
| Metric | CYRX | MRTN | Edge |
|---|---|---|---|
| Price as of 2026-07-23 close | $16.03 | $16.88 | |
| Market cap as of 2026-07-27 | $775M | $1.4B | |
| P/E as of 2026-07-27 | 10.19 | 105.18 | CYRX lower |
| Net margin as of 2026-07-27 | +41.6% | +1.5% | CYRX higher |
| Gross margin as of 2026-07-27 | +47.2% | +30.8% | CYRX higher |
| Operating margin as of 2026-07-27 | -21.4% | +1.9% | MRTN higher |
| ROE as of 2026-07-27 | +15.0% | +1.7% | CYRX higher |
| ROA as of 2026-07-27 | +9.9% | +1.3% | CYRX higher |
| Debt / equity as of 2026-07-27 | 0.38 | 0.00 | MRTN lower |
| Revenue growth (YoY) as of 2026-07-27 | -14.8% | -6.9% | MRTN higher |
| Revenue CAGR (3y) SEC XBRL | -9.4% | +9.0% | MRTN higher |
| Dividend yield as of 2026-07-27 | n/a | +1.5% | |
| Dividend streak (yrs) SEC XBRL | n/a | 4 | |
| Beta as of 2026-07-27 | 1.89 | 0.98 | |
| 1-year return as of 2026-07-23 close | +92.6% | +25.1% | CYRX higher |
Fundamentals: Finnhub, as of 2026-07-27. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-23.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.